Pricing Log in Create free account

Nkarta, Inc. (NKTX) vs PolyPid Ltd. (PYPD)

Nkarta, Inc. and PolyPid Ltd. are both Biotechnology companies. Nkarta, Inc. and PolyPid Ltd. are of similar size ($115.2M and $112.5M). Across the 9 metrics below, PolyPid Ltd. leads on 5 and Nkarta, Inc. on 4.

Valuation

Metric NKTX PYPD Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 0.53 25.59 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.42 n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (89.71%) (24.30%) (32.88%)
Free cash flow yield (72.03%) (55.78%) (23.13%)

Profitability

Metric NKTX PYPD Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (38.76%) (243.59%) (51.96%)
Return on assets (29.86%) (119.05%) (46.06%)
Return on invested capital (127.22%) 0.00% 0.00%

Growth

Metric NKTX PYPD Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 11.88% 57.43% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NKTX PYPD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.98 1.35 4.97
Net debt to EBITDA 2.35 0.39 1.01

Dividend

Metric NKTX PYPD Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric NKTX PYPD Biotechnology median
Market cap 112.45m 115.16m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack